To date, most analysts say health reform turned out pretty well for the pharmaceutical industry. But a detailed analysis by Deloitte Consulting says the indirect effects of reform will deliver a gut punch to the industry that will lead to full-scale transformation akin to what the telecommunications world has seen over the past three decades.
Health insurers, including locally based WellPoint Inc. and Advantage Health Solutions, have been looking to work with health care providers to form accountable-care organizations. But they also worry that the accountable-care concept will become nothing more than a negotiating tactic by hospitals and doctors.
Drugmakers including Pfizer Inc., AstraZeneca, Bristol-Myers Squibb Co. and Eli Lilly and Co. may provide more than $2 billion in drug discounts to senior citizens next year under a deal pharmaceutical companies made with the White House.
The Indianapolis-based firm that helps seniors and their care givers navigate the health care system won a nearly $1.2 million grant from the National Institutes of Health.
Ash Brokerage Corp. and InSource Inc. have merged to create Ash InSource LLC, a company with annual fixed and equity-indexed annuity sales of more than $1 billion.
Rising costs aren't the only impact of reform, say panelists taking part in a Power Breakfast sponsored by Indianapolis Business Journal.
In this new age of health care, ushered in by President Obama’s signing in March of a sweeping health care reform law, health care players are encouraged to remove the gloves if they want to reap the benefits of reform.
Major health insurers, including Indianapolis-based Anthem, are being ordered to a hearing to explain why they are eliminating child-only policies.
Celesio’s Lloyds Pharmacy and Aah Pharmaceuticals businesses sold about 800,000 tablets of generic Zyprexa before agreeing in 2008 to halt sales, Lilly said in a complaint filed in the High Court in London.
The CEO is on his way out and the board has been dissolved at Rehabilitation Hospital of Indiana, as its owners—Clarian Health and St. Vincent Health—work to pull the hospital closer to their own operations.
Health insurers won fairly broad leeway under key rules suggested by state insurance commissioners that will govern what kinds of expenses count toward meeting a new federal threshold to spend at least 80 percent of premiums dollars on medical care.
IU will use its Lilly Endowment grant to open its news Center for Law, Ethics and Applied Research in Health Information.
A drug-coated stent from Indiana-based Cook Medical was more effective than standard therapy for patients with blockages in an upper-leg artery, a study found.
Federal lawsuit, which stems from June 2008 flood that caused $167 million in damages and business income losses, alleges FEMA failed to pay the full amount the hospital is owed in federal funding.
The failure by state regulators to decide how much insurers must spend on patient care is scaring investors from health-plan stocks and complicating insurance company decisions.
IU School of Medicine associate professor Mark Rodefeld will use funding to further develop the pump, intended to combat a congenital heart defect that kills many children in their first year of life.
Eli Lilly and Co. launched its own blog this month, dubbed LillyPad, to try to start discussions about public policy and corporate social responsibility. The Indianapolis-based drugmaker also launched an accompanying Twitter feed.
Indianapolis-area hospitals spent billions on construction in the past decade and increasingly tried to poach patients from one another’s territories. Yet last year—one of the worst economically in recent history—21 of 26 hospitals still were able to show operating profits.
Advantis Medical Inc., a maker of cases and trays for surgical instruments, plans to add more than 100 jobs in Greenwood over the next five years.
